COVID-19 Vaccine 


Location SVMC COVID Resource Center  
Type (Vaccine) Patients over the age of 18 will have a choice of Pfizer, Moderna, or Johnson & Johnson, based on availability. Johnson & Johnson vaccine is in very limited supply until at least mid September.  

Gymnasium at Former Southern Vermont College Campus
982 Mansion Drive, Bennington


2 p.m. - 6 p.m. Monday – Wednesday
8 a.m. - noon Thursday - Saturday 

How to Schedule Appointments preferred. Walk-ins will be accommodated, there may be a significant wait. Those who register online may reserve their choice of vaccine. Schedule HERE.    
Who can Participate Anyone. The clinic is open to all who are eligible. At present, eligible people include everyone 12 and older, regardless of whether they live in Vermont or another state. It is anticipated that younger people will be eligible as early as this fall. Everyone under the age of 18 must be accompanied by parent or guardian. SVHC will participate in the Vermont Department of Health's plan to provide booster shots to all eligible people and will share details as they become available. Our physicans recommend that pregnant patients get vaccinated  
Cost Vaccines are free, with no cost to patients.  



For information about testing, visit the testing page


As with other vaccines, a small percentage of individuals may experience a brief period of fatigue, soreness at the injection site, and headache.

There are still unknowns, like how long the protection will last and how often we will need to be revaccinated. We trust that science will answer those questions, once the data is available.


Those 12 and older can register here. Those without access to the Internet may call 855-722-7878. Note that this timeline could change. We will use this website, our professional networks, medical practices, local media, social media, our e-newsletter, and other means to notify people how and when they can get their vaccine. We are not collecting names for a "waiting list."  

None of the COVID-19 vaccines currently in development in the United States use the live virus. Instead, they use just a small piece of the virus, either a protein or genetic material, to teach our immune systems how to recognize and fight it. The small piece of the virus used cannot multiply in the way necessary to make us sick.

The Pfizer BioNTech COVID Vaccine includes mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3- phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose. See the complete fact sheet here.

The Moderna COVID Vaccine includes messenger ribonucleic acid (mRNA), lipids (SM-102, polyethylene glycol [PEG] 2000 dimyristoyl glycerol [DMG], cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC]), tromethamine, tromethamine hydrochloride, acetic acid, sodium acetate, and sucrose. See the complete fact sheet here.

In an emergency, like a pandemic, the FDA can issue an emergency use authorization, or EUA, to provide faster access to medicines and tests that may help. They can do this only during an emergency and only when there are no adequate, approved, and available alternatives. EUAs have been used to make COVID tests available to the public, and soon, we expect a few vaccines will be made available in this way. While less data is needed to get a EUA than FDA approval, it still takes tons of data. The benefit is that an EUA takes weeks, rather than months or years. EUAs are continuously evaluated and can be revoked if (a) the emergency ends, (b) the product is found to be unfit, or (c) the product is officially approved, cleared, or licensed by the FDA.

No. A small percentage of people who received the vaccine will get fatigue, soreness, inflammation, or headache. While these symptoms are similar to those experienced by those with COVID, they are a result of the vaccine teaching your body to respond to the virus, if it enters your body. These reactions have universally resolve in a short amount of time, usually less than one day.  It does take about 2 weeks for the vaccine to provide immunity. A person could encounter the virus and become infected just before or just after receiving the vaccine, before the protection takes effect, which could lead to someone thinking that the vaccine had made them ill.

All but one of the vaccines in Phase III clinical trials requires two shots. The first shot starts building protection. A second shot, a few weeks later, is needed to get the most protection. Think of it as a one-two punch.

Vaccines will be provided at 59 sites in 39 towns throughout Vermont. SVMC will conduct one site in Bennington. Bennington's branch of the Vermont Department of Health expects to conduct a site in Manchester.

Allergic reactions to the vaccine are very rare. If you have never had a reaction to another vaccine, you should not expect to have a reaction to this one. Complete information is available here. 

There are many considerations that will help determine if we can quit wearing masks, get together with friends, and travel again. It is best to look to the experts at the Vermont Department of Health or your state’s department of health. Continuing a (maybe slightly loosened) set of precautions will help ensure our entire community is protected before we relax. And remember, you’re never fully protected and the best protection you can get from the vaccine will be  after your second shot.

There are still unknowns, like how long the protection will last and how often we will need to be revaccinated. We trust that science will answer those questions, once the data is available.

Theme picker

Theme picker

Theme picker

Our Services


A commitment to excellence and a patient-centered approach sets Southwestern Vermont Health Care apart.

 Cancer Care
 Primary Care
 Rehab & Residential Care
View All Services

Theme picker

Theme picker

Theme picker

Theme picker

Theme picker